Boston Scientific (BSX)

When you think about stock picks for 2024 related to artificial intelligence, the first name that likely comes to mind is Nvidia (NASDAQ:NVDA). If not…

3 Healthcare Stocks to Pick Up Before the Year-End Rally

By Muslim Farooque, InvestorPlace Contributor Nov 28, 2023

Explore the potential of healthcare stocks as the U.S. charges ahead with $4.3 trillion in healthcare spending

3 Healthcare Stocks to Scoop Up as They Change the Medical Landscape

By Joel Baglole, InvestorPlace Contributor Nov 22, 2023

Consider one of these three leading-edge healthcare stocks from companies focused on significant medical innovations.

The Pros Got It Wrong: 3 Stocks to Sell Despite Recent Upgrades

By Chris Markoch, InvestorPlace Contributor Oct 18, 2023

These three stocks to sell may be good picks for nimble traders, but for long-term investors, it may be time to put them aside.

7 Affordable Stocks to Invest in as America’s Population Ages

By Alex Sirois, InvestorPlace Contributor Oct 12, 2023

Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors.

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains

By Will Ashworth, InvestorPlace Contributor Aug 30, 2023

When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. However, some of the most significant gains over the long…

Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal

By Samuel O'Brient, InvestorPlace Reporter Nov 29, 2022

Apollo Endosurgery is about to be acquired by Boston Scientific. Here's what this new deal means for BSX and for APEN stock.

7 Stocks to Sell for March

By Louis Navellier and the InvestorPlace Research Staff Feb 26, 2021

The market is starting to get volatile again and sector rotation is underway. Clear the decks by dumping these stocks to sell for March.

3 Biotech Stocks to Buy As Things Heat Up for the Sector

By Tyler Craig, Tales of a Technician Feb 18, 2021

Biotech stocks offer a textbook retracement pattern. The risk is low, and the reward is high. Here's how to play it.

14 AI Stocks to Stay Away From

By Louis Navellier, Editor, Growth Investor Feb 16, 2021

Whether in transportation, manufacturing or healthcare, don't touch any of these 14 AI-related stocks with a 10-foot pole. Here's why.

3 Under-Loved Biotech Stocks to Buy for Profits Into 2021

By Nicolas Chahine, InvestorPlace Contributor Dec 3, 2020

Biotech stocks are vulnerable to headlines, but these three have too much potential to ignore. Own them for a swing trade into 2021.

Don’t Count Out These 5 Growth Stocks Just Yet!

By Aaron Levitt, InvestorPlace Contributor Feb 18, 2020

Growth stocks continue to perform well despite recent market hiccups. These five firms have the potential to keep that growth going for the long haul.

3 Healthcare Stocks to Buy This Week Ahead of Earnings

By Thomas Niel, InvestorPlace Contributor Feb 4, 2020

The markets may be taking a dip, but these three healthcare stocks could be your portfolio's prescription as earnings season is in full swing.

3 Stocks to Buy That Will Hit New All-Time Highs in 2020

By Vince Martin, InvestorPlace Contributor Jan 8, 2020

Though the market is at all-time highs, not every stock can say the same. These three stocks to buy should reach new peaks in 2020.

3 Healthcare Stocks to Buy Before the End of 2019

By Tyler Craig, Tales of a Technician Dec 9, 2019

The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.

3 Big Stock Charts for Thursday: Boston Scientific, AES and IPG

By James Brumley, InvestorPlace Feature Writer Oct 10, 2019

Stock charts of BSX, IPG and AES are moving into position for possible swing trades.

3 Big Stock Charts for Tuesday: Boston Scientific, GM and United Airlines

By James Brumley, InvestorPlace Feature Writer Sep 10, 2019

The stock charts of BSX, UAL and GM are each at key turning points, though not all necessarily for the better.

Boston Scientific Corp.’s proposed $3.7 billion acquisition of medical device maker Axonics Inc. will likely be scrutinized by the US Federal Trade Commission because the companies are the dominant providers of some treatments for urinary incontinence, according to antitrust experts.

Boston Scientific (BSX)

Citi Just Raised Its Price Target on These 3 Stocks

Needham Just Boosted Its Price Target on These 3 Stocks

BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024

7 Healthcare Stocks Taking Medicine to the Next Level

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Boston Scientific (BSX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

BSX Stock Predictions, Articles, and Boston Scientific News

Subscriber Sign in